openPR Logo
Press release

Angioplasty Balloons Market Industry Insights, Trends and Forecast up to 2023

11-15-2017 11:15 AM CET | Health & Medicine

Press release from: TMR - Research Reports

Angioplasty Balloons Market Industry Insights, Trends

According to a TMR analyst, “The global market for angioplasty balloons is likely to witness a 3.5% CAGR from 2015 to 2023. The market is expected to rise from a valuation of US$1.93 bn in 2016 and is anticipated to reach US$2.55 bn by 2023.” The segment of normal balloons is anticipated to lead the global market for angioplasty balloons for the years to come. Nevertheless, the segment of drug coated balloons is likely to gain popularity over the coming years. Region-wise, the market is dominated by North America closely trailed by Europe. It is expected that North America will continue leading it reaching a valuation of US$993.70 mn by the end of 2023.

Read Report Overview @ https://www.transparencymarketresearch.com/angioplasty-balloons-market.html

"As indicated by the CDC, almost 610,000 deaths have taken place every year in the U.S. alone because of heart maladies as of late. This number is required to increment significantly further," states a TMR expert. He further includes, "There were about 8 mn individuals in the U.S. experiencing peripheral artery sickness in 2011. These numbers are likewise set to increment after some time, because of elements including the quick expanding geriatric populace, the rising number of diabetics and obese natives, and the general increment in negative way of life decisions and high anxiety levels. These numbers just point to a developing demand for medicinal gadgets, operative devices, and embeds."

With the quantity of coronary surgeries anticipated that would increment radically in the coming years, the interest for angioplasty balloons will in like manner indicate increases.

Request Sample Report @ https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=5627

Despite the fact that the entry rate by new angioplasty balloons producers is modest, the current players have as of late been embracing outrageous evaluating techniques to pick up market entrance and share. The price cuts they put on angioplasty balloons is getting them more clients, however is definitely diminishing the general income created in the market from a worldwide viewpoint.

As expressed by Healing Hearts, the costs of angioplasty balloons alongside other gears have decreased by nearly 40% in the most recent decade in India, one of the significant destinations for medical tourism worldwide. This is seriously harming the extent of innovative work endeavors facilitated by driving players and is required to hamper the market development rate extensively soon. Producers can rather concentrate on the arrival of new items as of now in the pipeline. The accomplishment of these items will enormously enhance the demand for angioplasty balloons and the general development rate of its worldwide market.

Request Angioplasty Balloons Market Report Brochure @ https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=5627

The global market for angioplasty balloons is likely to have a dense and highly dynamic competitive scenario of the years ahead, states Transparency Market Research (TMR) in a research report. The core players namely Abbott Laboratories, Cordis Corporation, and Boston Scientific held a share of 71.7% collectively in 2014 in the global angioplasty balloons market. TMR also states that the existing players might be threatened by the entry of new players in the market over the next couple of years, but the threat might stay moderate for some time now. This is mainly due to the expensive research and development involved in this field and the strict government policies that tend to differ from region to region. Moreover, the growth of the market is likely to have a slow place to make enough scope for the entry of new players. The race to stay ahead has given rise a plethora of innovations taking and product launches.

Buy Full Angioplasty Balloons Market Report @ https://www.transparencymarketresearch.com/checkout.php?rep_id=5627<ype=S

About TMR

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Each TMR syndicated research report covers a different sector - such as pharmaceuticals, chemicals, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, TMR’s syndicated reports strive to provide clients to serve their overall research requirement.

US Office Contact

90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Angioplasty Balloons Market Industry Insights, Trends and Forecast up to 2023 here

News-ID: 817917 • Views:

More Releases from TMR - Research Reports

Pulmonary Drugs Market is Expected to Reach US$ 28,082.1 Million by the End of 2024
Pulmonary Drugs Market is Expected to Reach US$ 28,082.1 Million by the End of 2 …
According to the research report, the global pulmonary drugs market is expected to be worth US$ 28,082.1 mn by the end of 2024 as compared to US$ 48,039.7 mn in 2015. Analysts calculate that the global market will plummet at a CAGR of -6.3% during the forecast period of 2016 and 2024. The market will thrive as the demand for combination drugs is anticipated to remain on the rise during
North America Ventricular Assist Device Market is rising to a valuation of US$ 1.07 Billion by 2024
North America Ventricular Assist Device Market is rising to a valuation of US$ 1 …
According to TMR, the opportunity in the North America market for VADs, which stood at US$0.4 bn in 2015, is likely to expand at a healthy CAGR of 9.20% between 2016 and 2024 and increase to US$1.07 bn by the end of the forecast period. The destination therapy (DT) segment has been reporting a greater application of VADs than the other two indication segments. It is expected to remain the
Dental Membrane and Bone Graft Substitutes Market to rise to US$ 922.6 Million by 2024
Dental Membrane and Bone Graft Substitutes Market to rise to US$ 922.6 Million b …
Transparency Market Research notes that innovation and expansion into emerging regions have served these companies well in strengthening their hold in the dental membrane and bone graft substitutes market. For instance, Switzerland-based Geistlich Pharma AG - a global manufacturer and supplier of dental products and devices - expanded its operations in Sydney, Australia and New Delhi, India in 2016. The global dental membrane and bone graft substitutes market is expected to
Human Vaccines Market is Estimated to Reach US$ 72.5 Billion by 2024
Human Vaccines Market is Estimated to Reach US$ 72.5 Billion by 2024
The global human vaccines market was valued at US$28.3 bn in 2015 and is estimated to reach US$72.5 bn by 2024, registering an 11.2% CAGR during the forecast period. By age group, pediatric vaccines accounted for a 57.5% share in the global human vaccines market in 2015. Adult vaccines, on the other hand, are expected to expand at a 13.2% CAGR from 2016 to 2024. Based on product, the pneumococcal segment

All 5 Releases


More Releases for Angioplasty

Angioplasty Balloon Market is Fueled by Increasing of Demand for Angioplasty Bal …
The Angioplasty Balloon Market research report provides an in depth examination of the key factors stimulating market expansion. It also sheds light on the challenges or restraining factors that are poised to hinder industry growth over the forecast timeframe. Growth rate, market share captured, and valuation estimates for each region, segment, and company are documented as well. View Report - https://www.theinsightpartners.com/reports/angioplasty-balloon-market/ Angioplasty balloon is used in various interventional procedures for the treatment
Angioplasty Balloons Market Report Up to 2031
Visiongain has published a new report on Angioplasty Balloons Market Report to 2031: Forecasts By Product Type (Normal, Drug-Eluting, and Cutting & Scoring Balloons), By Application (Coronary Artery Disease and Peripheral Artery Diseases) PLUS COVID-19 Recovery Scenarios. How has COVID-19 Impacted on Angioplasty Balloons Market COVID-19 pandemic adversely affected over 200 countries worldwide. Companies have been pressured to upsurge production capacity and raise the supply of products and other commodities. The pandemic
Estimation: Angioplasty Balloons Market COVID-19 impact
The global angioplasty balloons market is estimated to surpass $3,043.8 million by 2027, exhibiting a CAGR of 3.3% from 2020 to 2027. OFFERINGS OF THE REPORT: The report offers comprehensive analysis of the global angioplasty balloons market by thoroughly studying different aspects of the market including major segments, market statistics, market dynamics, regional market outlook, investment opportunities, and top players working towards the growth of the market. The report also sheds light on
03-15-2021 | Health & Medicine
Fact.MR
Angioplasty Balloons Market: Semi-compliant balloons to be the most preferred an …
Balloon angioplasty is increasingly being used to carry out various specific tasks during surgeries, such as scoring, cutting, and drug eluting. Manufacturers of angioplasty balloons are focusing on improving patient outcomes by constantly upgrading their existing products. Balloon angioplasty is widely preferred for being minimally-invasive, and can be performed under local anaesthesia, wherein, the patient can be discharged within 24 hours after the surgery, in most cases. Moreover, drug-coated balloon
Angioplasty Balloons Market Opportunity Analysis, 2018-2026
Angioplasty balloon is a medical device that is used for surgical widening or unblocking of a blood vessel, especially a coronary artery. A noticeable increase in health conditions have been is observed due to some factors that cause heart related diseases such as obesity, poor diet, and extra cholesterol. .Coronary artery disease is a life threatening disease which occurs due to insufficient supply of blood to the heart, leading to
Angioplasty Balloons Market : Regional & Competitive Analysis
According to a TMR analyst, “The global market for angioplasty balloons is likely to witness a 3.5% CAGR from 2015 to 2023. The market is expected to rise from a valuation of US$1.93 bn in 2016 and is anticipated to reach US$2.55 bn by 2023.” The segment of normal balloons is anticipated to lead the global market for angioplasty balloons for the years to come. Nevertheless, the segment of drug